Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Citius Pharmaceuticals Inc (CTXR)

1.77   -0.15 (-7.81%) 03-05 09:21
Open: 1.82 Pre. Close: 1.92
High: 1.88 Low: 1.61
Volume: 20,448,611 Market Cap: 223M
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products. It primarily focuses on developing anti-infective, cancer care, and prescription products. The company develops Mino-Lok, which is in Phase III clinical trials for the treatment and salvage of infected central venous catheters in patients with catheter related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction tissue expander infections following breast reconstructive surgeries; and Hydro-Lido, a topical formulation of hydrocortisone and lidocaine that is intended for the treatment of hemorrhoids. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.882 - 1.897 1.897 - 1.908
Low: 1.582 - 1.597 1.597 - 1.607
Close: 1.749 - 1.774 1.774 - 1.791

Technical analysis

as of: 2021-03-05 8:44:38 AM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 2.61     One year: 3.39
Support: Support1: 1.16    Support2: 0.97
Resistance: Resistance1: 2.24    Resistance2: 2.90
Pivot: 1.88
Moving Average: MA(5): 1.96     MA(20): 1.75
MA(100): 1.22     MA(250): 1.06
MACD: MACD(12,26): 0.19     Signal(9): 0.21
Stochastic oscillator: %K(14,3): 38.88     %D(3): 44.45
RSI: RSI(14): 52.54
52-week: High: 2.90  Low: 0.41  Change(%): 178.3
Average Vol(K): 3-Month: 1194619  10-Days: 4727693

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
CTXR has closed above bottom band by 41.1%. Bollinger Bands are 267.9% wider than normal. The large width of the bands suggest high volatility as compared to CTXR's normal range. The bands have been in this wide range for 15 bars. This is a sign that the current trend might continue.

Headline News

Thu, 04 Mar 2021
Citius Pharmaceuticals to Feature Product Candidates Including Stem-Cell Therapy for COVID-19-Related Acute Respiratory Conditions at H.C. Wainwright Global Life Sciences Conference March 9-10 - Yahoo Finance

Wed, 24 Feb 2021
Is Citius Pharmaceuticals Inc (CTXR) Stock a Smart Value? - InvestorsObserver

Mon, 22 Feb 2021
Premarket Mover: Citius Pharmaceuticals Inc (CTXR) Up 15.05% - InvestorsObserver

Fri, 19 Feb 2021
CTXR Stock: 9 Things to Know About the Biotech Citius Pharma as Shares Surge - InvestorPlace

Fri, 19 Feb 2021
CTXR Stock Price Increases Over 25% Pre-Market: Why It Happened - Pulse 2.0

Fri, 19 Feb 2021
Citius Pharmaceuticals Announces Closing of $76.5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules - Yahoo Finance

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 56
Shares Float (M) 37
% Held by Insiders 22.15
% Held by Institutions 13.89
Shares Short (K) 1,140
Shares Short P. Month (K) 1,650

Stock Financials

EPS -0.448
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 0.610
Profit Margin
Operating Margin
Return on Assets (ttm) -27.5
Return on Equity (ttm) -57.7
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.319
Qtrly Earnings Growth
Operating Cash Flow (M) -17
Levered Free Cash Flow (M) -10

Stock Valuations

PE Ratio -3.95
PEG Ratio
Price to Book value 2.90
Price to Sales
Price to Cash Flow -5.81

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.